Dr. del Cid will treat patients at the Retina Group’s Plantation, Hollywood, Fort Lauderdale and Boca Raton offices.
Dr. del Cid received his MD from Tulane University, according to his bio. He then completed an ophthalmology residency from University of Texas Health Science Center in San Antonio and a fellowship in vitreoretinal disease and surgery with the Cincinnati Eye Institute at the University of Cincinnati.
Dr. del Cid has a research interest in the use of non-steroidal therapeutics in ophthalmology.
Related Articles on Ophthalmologists:
40 Ophthalmology-Driven Surgery Centers to Know
Ophthalmologist Dr. Allen Beck Appointed to Childhood Glaucoma Research Network Exec Committee
Ophthalmologist Steven E. Feldon Named to NIH Study Section
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
